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Abstract
           
Background:  Implantable Cardioverter-defibrillators (ICD) reduce mortality in survivors of 
cardiac arrest (CA).   We investigated the predictors of mortality after ICD implantation in 
survivors   of   CA.                                                                                        
Methods: Retrospective review of clinical records and social security death index of all patients 
who received an ICD in a preexisting database of survivors of CA at the University of Pittsburgh 
Medical Center was performed. Multivariate analyses using the Cox proportional hazard model 
were performed with backward elimination to identify independent predictors of the time to 
death,  and  Kaplan-Meier  curves  were  plotted.                                                          
Results: Eighty patients (64 men) with a mean age of 64.4±12.5 years were followed for 4.7±2.3 
years after ICD implantation. Survival rates were 93.8%, 65% and 50% at 1, 5, and 10 years, 
respectively. Independent predictors of time to death were determined to include age (hazard 
ratio (HR) = 1.91 per 10-year increase, p = 0.003), serum creatinine ≥ 1.3 mg/dL (HR = 2.56, p 
= 0.004), and QRS width >120 ms (HR = 5.14, p = 0.012).                                  
Conclusions:  In this sample of ICD recipients secondary to CA, older age, elevated serum 
creatinine, and wider QRS duration were independent predictors of mortality. The presence of 
more than one risk factor in the same patient was associated with higher mortality rates. 
Whether interventions such as biventricular pacing can offset this increase risk of death warrants 
further investigation.
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            Sudden cardiac death accounts for 50% of all cardiac related mortality in the developed 
countries and half of these deaths occur outside hospitals1. Fatal arrhythmias are the leading 
causes of cardiac arrests (CA), mostly due to either delayed or unavailable defibrillation therapy. 
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Implantable cardioverter-defibrillators (ICDs) provide timely electrical shocks in the face of 
near-fatal arrhythmias. Hence, they prolong survival of individuals, who already had a CA, as 
shown in secondary prevention ICD trials2-4.  Despite the salutary effects of ICDs, defibrillator 
recipients have higher total mortality compared to the general population, which may be related 
to their underlying cardiac condition or other comorbidities5,6.                                                 
               Multiple studies have looked at the predictors of all-cause mortality as well as 
cardiovascular or arrhythmic deaths in ICD recipients7,8, with inconsistent results. Many of these 
studies focused on patients with predominantly primary indication for ICD implantation. Factors 
such as detectable troponin T levels conferred a poor prognosis despite the ICD9. In other patient 
populations, the ICD did not improve survival in patients with higher blood pressure9 or in those 
who were on therapy with statins8.                                                                                     
            We evaluated the predictors of total mortality in CA survivors, after implantation of an 
ICD, with the primary goal of determining and possibly averting non-arrhythmic causes of death 
that may still claim patient lives after the implantation of the defibrillator.                         
Methods
Study   Subjects   and   Settings                                                                 
               We analyzed a preexisting database of all patients admitted to the University of 
Pittsburgh Medical Center with a concomitant diagnosis of acute myocardial infarction (AMI) 
and CA (n = 48). The Institutional Review Board of the University of Pittsburgh approved this 
study. In that database, those patients were matched by age, gender, and left ventricular ejection 
fraction (LVEF) to patients with CA outside the context of AMI (n = 48). Of the overall cohort 
(n=96), only patients implanted with an ICD (n=80) were included in this analysis.            
            Patients were followed up for a mean period of 4.7±2.3 years. Mortality status was 
ascertained from electronic medical record or social security mortality index.   Data on co-
morbidities, clinical laboratory values, electrocardiogram, echocardiograms, and family history 
were obtained by examining the electronic medical records.                                  
Statistical   Methods                                                                                
            Means (± standard deviations) and percentages were use to describe continuous and 
categorical variables, respectively. First, univariate analyses were done using the log rank test 
for equality across strata for categorical variables and the univariate Cox proportional hazard 
regression model for continuous variables. Multivariate Cox proportional hazard regression 
linear models were used including variables with a p value ≤ 0.1, using backward elimination. 
Other predictors of mortality shown in published literature were similarly tested using backward 
elimination. Variables selected for multivariate analyses were used to build a final model after 
checking for interactions and proportionality assumptions. Kaplan-Meier curves were plotted for 
variables found significant on multivariate Cox model by dichotomizing markers according to 
clinical relevance. Finally, the effect of the presence of one or more mortality predictor was 
evaluated by plotting Kaplan-Meier survival curves and using the log rank test. P values ≤ 0.05 
were considered statistically significant. All statistical analyses were performed on SAS 
statistical package (version 9.1.3).                                                                             
Results
               Eighty patients (64 men) with a mean age of 64.4±12.5 years underwent ICD 
implantation. Of those, 47 patients had only CA, while the remaining had both AMI and CA. 
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Fifty percent of the cohort (n = 40) died during follow-up, with a mean survival of 5.9±3.1 years 
(Range 0.16-13.7 years). Kaplan-Meier survival curve for the overall cohort is shown in Figure 
1. The 1-year, 5-year and 10-year survival rates after CA and ICD implantation were 93.8% , 
65%, and 50%, respectively.  
Figure1. Kaplan-Meier Survival Curves the whole Cohort of ICD Recipients Secondary to 
Sudden Cardiac Arrest (n=80)
            Baseline characteristics differed significantly between patients who died during follow-
up and those who survived, as shown in Table 1. In brief, older age, higher serum creatinine, 
wider QRS complex, presence of coronary artery disease, a higher white blood cell count, lower 
platelet and creatinine phosphokinase counts, and a higher occurrence of atrial fibrillation were 
more prevalent in those patients who died. 
            Backward selection methods yielded only age, serum creatinine, and QRS width as 
independent predictors of the time from ICD implantation to death during follow-up. The 
multivariate Cox proportional hazard model including these 3 variables is shown in Table 2. 
There was no statistical interaction between any of these independent predictors of time to death 
in our population. Also, the test of proportionality was not significant neither collectively nor for 
each of the final variables in the model. 
            A higher risk profile was defined by dichotomizing serum creatinine at  >1.3mg/dL, the 
QRS width at > 120 ms, and age at > 70 years. As shown in Figure 2, there was a dose-
dependent increase in the risk of mortality with the increase in number of these risk factors in a 
given patients (p<0.001).
Discussion
            This study shows that higher age, elevated serum creatinine levels, and a wider QRS 
complex at the time of ICD implantation are independent predictors of time to death in survivors 
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of CA.  Our study cohort is closely comparable to the population of patients studied in the AVID 
trial. The unadjusted 3-year survival rates in AVID was 64.1% in the control arm and 75.4% in 
the ICD arm. Our 3-year survival rate is 82.5%, which is consistent with the fact that the ICD 
confers a survival benefit in this high-risk population of CA survivors. Patients with 2 or more 
risk factors in our cohort had however a 3-year survival rate of 50%, which is even lower than 
that of the no-ICD arm of AVID. This finding underscores the nature of competing causes of 
death in any individual patient whereby, despite a significant reduction in the risk of arrhythmic 
death with the ICD, patients are still likely to die sooner of other causes if they are older, have 
renal insufficiency, have a wider QRS complex which may exacerbate heart failure, or any 
combination of these risk factors. Whether the presence of 2 or more of these risk factors in one 
patient would overwhelm any benefit from the ICD deserves to be investigated. Until such data 
is available, survivors of CA remain indicated for ICD implantation regardless of age and QRS 
width.
Table 1. Characteristics of Study Subjects Prior to ICD Implantation (n=80) by Mortality Status
COPD=Chronic obstructive pulmonary disease, SCA=Sudden cardiac arrest, CAD= Coronary artery disease. P 
value refers to log rank p for categorical variables and Cox proportional model p for continuous variable
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Table 2. Multivariate Cox Proportional Hazard Ratio for Final* Variables
*These variables were selected using backward elimination from a set of variables with p<0.1 in univariate analysis 
and shown to be important mortality predictor in current literature. 
Figure 2. Kaplan Meier Curves Showing the Influence of the Presence of zero (n=35), one 
(n=33), and two or more (n=12) risk factors (Age > 70 years, Serum Creatinine >1.3 mg/dL, 
QRS Duration > 120ms) on Survival.
            Identifying baseline predictors of overall mortality can help reduce total mortality in ICD 
recipients if reversible causes of mortality are identified. Others have reported that women are 
less likely than men to benefit from ICD implantation10. Our results, however, do not confirm 
this finding and this is in keeping with larger published studies7,11,12. Also, similar to other 
studies,  higher  age11,12  and  worse kidney function11,13-16  were  independent  predictors  of 
mortality   in   our   cohort.                                                            
            In keeping with the findings of published ICD trials17-19, longer QRS duration was 
associated with decreased survival in our cohort.   Prolonged QRS is associated with higher 
levels of ventricular dyssynchrony, with reduction in the rate of rise of ventricular pressure, and 
with reduction in diastolic filling times20,21. Biventricular pacing in a select population of 
patients with wide QRS complex, low LVEF, and advanced symptoms of heart failure has been 
shown to decrease mortality and morbidity.  Whether a survival benefit is conferred by 
biventricular pacing in survivors of CA with wide QRS complex remains to be proven.  
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Limitations  
            Our current study has a number of limitations. First, it is a retrospective study, with a 
small sample size, mostly consisting of white males with secondary indication for ICD 
implantation. Extrapolating our results to other patient populations of different ethnicities or 
implanted with ICDs for primary prevention of CA may not be feasible. Second, although all-
cause mortality is an important cardiovascular end-point, disease specific mortality data would 
have   provided   valuable   information.                                                
            In conclusion, this hospital-based cohort of CA survivors has higher survival compared 
to a historical control from the non-ICD arm of the AVID trial, except when other risk factors 
including advanced age, wide QRS complex, and the presence of renal insufficiency are 
documented.   Future   studies   investigating   the   effect   of   aggressive   management   of   renal 
dysfunction and the potential role of biventricular pacing in correcting ventricular conduction 
abnormalities on total mortality in this patient population may be warranted.
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